Patents by Inventor Ting-Bin Yu

Ting-Bin Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190091152
    Abstract: Novel encapsulated umirolimus and umirolimus polymer conjugate formulations having enhanced permeability and retention at tumor sites. Also provided are methods for treating cancer by administering the umirolimus formulations.
    Type: Application
    Filed: November 30, 2018
    Publication date: March 28, 2019
    Inventors: Ting-Bin Yu, Shih-Horng Su
  • Patent number: 10172796
    Abstract: Novel encapsulated umirolimus and umirolimus polymer conjugate formulations having enhanced permeability and retention at tumor sites. Also provided are methods for treating cancer by administering the umirolimus formulations.
    Type: Grant
    Filed: December 2, 2013
    Date of Patent: January 8, 2019
    Assignee: Manli International Ltd.
    Inventors: Ting-Bin Yu, Shih-Horng Su
  • Publication number: 20170119666
    Abstract: A stable liposomal formulation for ocular delivery of an alpha 2 adrenergic agonist. The formulation contains a liposome that includes a lipid bilayer including a phosphatidylcholine. An alpha 2 adrenergic agonist is encapsulated in the liposome.
    Type: Application
    Filed: October 29, 2015
    Publication date: May 4, 2017
    Inventors: Ting-Bin Yu, Zhiwei Shi, Shih-Horng Su, Tina Howden
  • Publication number: 20170065520
    Abstract: A stable liposomal formulation for treating cancer. The formulation includes liposomes containing one or more of POPC, DMPC, and DOPC and one or more of the anti-cancer drugs sirolimus, umirolimus, and everolimus encapsulated in the liposomes. Also provided are efficient remote film loading methods for loading the liposomes with the anti-cancer drugs and methods for treating cancer with the liposomal formulations.
    Type: Application
    Filed: September 9, 2015
    Publication date: March 9, 2017
    Inventors: Ting-Bin Yu, Zhiwei Shi, Shih-Horng Su
  • Publication number: 20170042809
    Abstract: A stable liposomal formulation for ocular delivery of a carbonic anhydrase inhibitor. The formulation contains (i) a liposome that includes a lipid bilayer formed of a phosphatidylcholine, and (ii) a carbonic anhydrase inhibitor encapsulated in the liposome. Also provided is a method for treating an ocular disorder with the formulation.
    Type: Application
    Filed: August 11, 2015
    Publication date: February 16, 2017
    Inventors: Ting-Bin Yu, Zhiwei Shi, Shih-Horng Su, Tina Howden
  • Patent number: 8834915
    Abstract: Methods for producing drug-containing bioabsorbable fibers. Also disclosed are methods for treating diseases using a bioabsorbable drug delivery device.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: September 16, 2014
    Assignee: Manli International Ltd.
    Inventors: Shih-Horng Su, Ting-Bin Yu, Minh Nguyen
  • Publication number: 20140154305
    Abstract: Novel encapsulated umirolimus and umirolimus polymer conjugate formulations having enhanced permeability and retention at tumor sites. Also provided are methods for treating cancer by administering the umirolimus formulations.
    Type: Application
    Filed: December 2, 2013
    Publication date: June 5, 2014
    Applicant: Manli International Ltd.
    Inventors: Ting-Bin Yu, Shih-Horng Su
  • Publication number: 20130256928
    Abstract: Methods for producing drug-containing bioabsorbable fibers. Also disclosed are methods for treating diseases using a bioabsorbable drug delivery device.
    Type: Application
    Filed: March 30, 2012
    Publication date: October 3, 2013
    Applicant: DuNing Incorporated
    Inventors: Shih-Horng Su, Ting-Bin Yu, Minh Nguyen